Loading
A two-week nationwide law enforcement action that resulted in 193 criminal indictments in nationwide health care fraud and opioid abuse schemes includes nine cases in Florida’s Middle District and four people on the west coast of Florida.
A statement from the U.S. Justice Department says the 193 cases resulted in the submission of more than $2.75 billion in alleged false billings. Federal agents have also seized more than $231 million in cash, luxury vehicles, gold and other assets in these cases.
Cases on the west coast of Florida include:
A registered nurse who worked in intensive care units, Brewer, officials allege "engaged in two similar criminal schemes to divert fentanyl at five different Tampa-area hospitals across seven different dates. In the first scheme, which Brewer executed on several occasions, Brewer stole fentanyl by checking out 100 mL bags of liquid fentanyl from locked controlled substance cabinets but keeping the bags for himself rather than administering them to patients or returning them. In the second scheme, Brewer used hospital computers to research which patients were receiving fentanyl intravenously, entered those patients’ rooms even when he had no medical reason to do so, and surreptitiously siphoned fentanyl from their IV drip bags into his own vessel; Brewer would then go to the hospital bathroom, where he would inject himself with stolen fentanyl."
Sometimes, Brewer allegedly tried to cover his theft by replacing the fentanyl he withdrew with an equivalent volume of saline, but sometimes he did not, the release states. "In both scenarios, however, Brewer’s actions deprived the most vulnerable patients of needed medicine," the release states. "Brewer was caught when colleagues observed him acting impaired during a shift and the person who entered the bathroom immediately after Brewer exited found a bloody paper towel and needle inside."
Hospital officials subsequently examined records and video and discovered Brewer’s pattern of diversion, the release states.
The alleged scheme charges that Desselle, through his company, Desselle’s Sky High Enterprise LLC, paid marketers on a per-patient basis to recruit Medicare beneficiaries for cancer genetic testing (“CGx”) tests that weren't medically necessary. Medicare paid approximately $4.5 million on CGx claims billed for these beneficiaries, the U.S. Attorney’s Office says.
The indictment alleges that LeBeau and Lebrecht conspired to pay, and paid, patient recruiters per patient referral that Prestigious billed to Medicare. Medicare paid approximately $1.3 million based on the false and fraudulent claims, officials allege.
Descriptions of each case involved in today’s enforcement action are available on the Justice Department’s website.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
